FOX04-DRI·ALASKA·VERIFIED MAY 13, 2026

Is FOX04-DRI legal in Alaska?

CAVEATS APPLY

Preclinical 43-aa senolytic peptide; no human clinical trials registered; no FDA approval; pre-IND. No state-level peptide restrictions beyond federal law in Alaska.

CATEGORY · NO APPROVAL

Full status breakdown

FEDERAL · STATE · SPORT-BODY

Federal status

FDA approval

no approval

FDA SOURCE ↗

DEA scheduling

not scheduled

DEA ORANGE BOOK ↗

503A compounding

Bulks list: not on list

Do-not-compound list: not on list

No PCAC vote.

SOURCE ↗

FDA Warning Letters

none on record for this compound

Shortage status

not currently on shortage list

Sale framing

Research-use-only posture: Pre-IND. FDCA §505 applies if marketed for human use.

Personal possession: Not federally criminalized.

SOURCE 1 ↗

Alaska — state-specific

Sport-body status

WADA 2026

not on prohibited list

Not explicitly named.

WADA LIST ↗

USADA

unknown

SOURCE ↗

NCAA

unknown

SOURCE ↗

What we couldn’t verify

Also known as

4 ALIASES

FOX04-DRI is also marketed or referenced under the following names (vendor pseudonyms, brand names, chemical identifiers):

FOXO4-DRI
FOXO4-D-Retro-Inverso
senolytic peptide
Baar et al. 2017 peptide

FOLLOW-ONS

Back to peptide legality lookup — pick a different compound or state
Peptide pricing index — what each compound costs per mg across audited vendors
Janoshik COA verifier — a separate question from legality: does the COA the vendor cites actually exist?

FOX04-DRI legality in other US states

State-by-state legal status for the same compound. Federal classification holds, state law varies.

Is FOX04-DRI legal in Alaska?

Full status breakdown

Federal status

Alaska — state-specific

Sport-body status

What we couldn’t verify

Also known as

Related

FOX04-DRI legality in other US states

Receipts in your inbox. Once a month.